Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-25 @ 4:02 PM
Study NCT ID:
NCT03296657
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2017-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Analysis of Stannous Fluoride in GCF and Subgingival Plaque
Sponsor:
Procter and Gamble
Organization:
Study Overview
Official Title:
A Pilot Study to Evaluate Stannous Fluoride in GCF and Subgingival Plaque
Status:
COMPLETED
Status Verified Date:
2017-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.
Detailed Description:
This is pilot study involving approximately 20 subjects with at least 20 dental pockets between 2- 4mm with bleeding for sampling. Subjects will have up to 10 sites identified as "sampling sites" that will have supragingival plaque, subgingival plaque, and gingival crevicular fluid (GCF) collected at Baseline, 30 minutes, 24 hours, and Week 2.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: